Literature DB >> 21847058

Chemotherapy definitions and policies for thymic malignancies.

Nicolas Girard1, Rohit Lal, Heather Wakelee, Gregory J Riely, Patrick J Loehrer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21847058     DOI： 10.1097/JTO.0b013e31821ea5f7

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  24 in total

Review 1.  Paraneoplastic and Therapy-Related Immune Complications in Thymic Malignancies.

Authors:  Elizabeth A Lippner; David B Lewis; William H Robinson; Tamiko R Katsumoto
Journal:  Curr Treat Options Oncol       Date:  2019-06-22

Review 2.  Thymic tumors and immune checkpoint inhibitors.

Authors:  Shintaro Yokoyama; Hiroaki Miyoshi
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

3.  Pretreatment biopsy for thymic epithelial tumors-does histology subtype matter for treatment strategy?

Authors:  Sukhmani K Padda; Marlies Keijzers; Heather A Wakelee
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

4.  How large databases may impact clinical practices for rare tumors-postoperative chemotherapy in thymic malignancies.

Authors:  Nicolas Girard; Claire Merveilleux du Vignaux
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

Review 5.  Neuroendocrine tumors of the thymus: the oncologist point of view.

Authors:  Nicolas Girard
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 6.  Management of thymic tumors: a European perspective.

Authors:  Enrico Ruffini; Federico Venuta
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

Review 7.  Novel Agents in the Treatment of Thymic Malignancies.

Authors:  Claire Merveilleux du Vignaux; Jean-Michel Maury; Nicolas Girard
Journal:  Curr Treat Options Oncol       Date:  2017-08-10

Review 8.  Pediatric thymomas: report of two cases and comprehensive review of the literature.

Authors:  Annabelle L Fonseca; Doruk E Ozgediz; Emily R Christison-Lagay; Frank C Detterbeck; Michael G Caty
Journal:  Pediatr Surg Int       Date:  2013-12-10       Impact factor: 1.827

9.  Treatment updates in advanced thymoma and thymic carcinoma.

Authors:  Matthew A Gubens
Journal:  Curr Treat Options Oncol       Date:  2012-12

10.  Gemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendations.

Authors:  Yusuke Okuma; Yukio Hosomi; Kageaki Watanabe; Satoshi Takahashi; Tatsuru Okamura; Tsunekazu Hishima
Journal:  Int J Clin Oncol       Date:  2015-12-08       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.